Labcorp Holdings Inc. (LH) EV/Sales Ratio: 2.00x
Is Labcorp Holdings Inc.’s EV/Sales ratio high or low?
Labcorp Holdings Inc.'s EV/Sales ratio of 2.00x is in line with its 5-year average of 1.88x, near the high end of its 5-year range (1.41x–2.25x).
As of Sunday, June 14, 2026. 4.46% below its 12-month average of 2.09x.
LH EV/Sales Ratio Chart
LH Average EV/Sales Ratio Chart
LH Current vs Average EV/Sales Ratio Chart
LH EV/Sales Ratio Metrics
EV/SALES RATIO
2.00x
EV/SALES RATIO AVG TTM
2.09x
EV/SALES RATIO AVG 3Y
1.99x
EV/SALES RATIO AVG 5Y
1.88x
EV/SALES RATIO AVG 10Y
1.88x
EV/SALES RATIO AVG 15Y
1.87x
EV/SALES RATIO AVG 20Y
1.91x
CURRENT VS TTM AVG
-4.46%
CURRENT VS 3Y AVG
+0.28%
CURRENT VS 5Y AVG
+6.48%
CURRENT VS 10Y AVG
+6.14%
CURRENT VS 15Y AVG
+6.86%
CURRENT VS 20Y AVG
+4.56%
LH Competitors' EV/Sales Ratio
| NAME | MARKET CAP | EV/SALES RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Labcorp Holdings Inc. (LH) | $21.83B | 2.00x | 2.09x | 1.99x | 1.88x |
| Mettler-Toledo International Inc. (MTD) | $22.86B | 6.14x | 7.34x | 7.51x | 8.17x |
| BioNTech SE (BNTX) | $22.90B | 3.58x | 4.18x | 3.71x | 3.46x |
| United Therapeutics Corporation (UTHR) | $23.17B | 7.79x | 6.47x | 5.72x | 5.77x |
| Waters Corporation (WAT) | $23.17B | 9.10x | 7.04x | 7.13x | 7.32x |
| Moderna, Inc. (MRNA) | $19.80B | 8.59x | 5.99x | 5.02x | 6.80x |
| Veeva Systems Inc. (VEEV) | $25.92B | 7.44x | 12.44x | 13.31x | 15.66x |
| Hologic, Inc. (HOLX) | $16.97B | 4.25x | 4.02x | 4.39x | 4.15x |
| DexCom, Inc. (DXCM) | $29.08B | 6.21x | 6.62x | 10.21x | 13.86x |
| Biogen Inc. (BIIB) | $29.53B | 3.33x | 2.79x | 3.30x | 3.57x |
Understanding EV/Sales
Enterprise Value (EV) = Market Cap + Total Debt - Cash
Sales = Total Revenue (TTM)
EV/Sales is commonly used because:
- It works for unprofitable companies where P/E doesn't apply
- Revenue is harder to manipulate than earnings
- It supports comparisons across companies at different profitability stages
- It is frequently used for software and other revenue-growth-focused companies
Note: EV/Sales does not include margin, debt maturity, cash conversion, or growth durability by itself.
Labcorp Holdings Inc. EV/Sales Ratio Formula & Definition
EV/Sales = Enterprise Value / Revenue (TTM)
Enterprise value to sales compares total company value to revenue, useful across capital structures and for unprofitable companies.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Labcorp Holdings Inc. EV/Sales Ratio FAQ
- What is the EV/Sales ratio for Labcorp Holdings Inc. (LH)?
- The EV/Sales ratio for LH stock is 2.00x.
- Is Labcorp Holdings Inc.'s EV/Sales ratio high or low?
- Labcorp Holdings Inc.'s EV/Sales ratio of 2.00x is in line with its 5-year average of 1.88x, near the high end of its 5-year range (1.41x–2.25x).
- What is the TTM average EV/Sales ratio for Labcorp Holdings Inc. (LH)?
- The TTM average EV/Sales ratio for LH stock is 2.09x.
- What is the 3Y average EV/Sales ratio for Labcorp Holdings Inc. (LH)?
- The 3Y average EV/Sales ratio for LH stock is 1.99x.
- What is the 5Y average EV/Sales ratio for Labcorp Holdings Inc. (LH)?
- The 5Y average EV/Sales ratio for LH stock is 1.88x.
- What is the 10Y average EV/Sales ratio for Labcorp Holdings Inc. (LH)?
- The 10Y average EV/Sales ratio for LH stock is 1.88x.
- What is the 15Y average EV/Sales ratio for Labcorp Holdings Inc. (LH)?
- The 15Y average EV/Sales ratio for LH stock is 1.87x.
- What is the 20Y average EV/Sales ratio for Labcorp Holdings Inc. (LH)?
- The 20Y average EV/Sales ratio for LH stock is 1.91x.
Labcorp Holdings Inc. EV/Sales Ratio History
| DATE | EV/SALES RATIO |
|---|---|
| 2026-06-12 | 2.00x |
| 2026-06-11 | 2.00x |
| 2026-06-10 | 2.02x |
| 2026-06-09 | 2.03x |
| 2026-06-08 | 1.98x |
| 2026-06-05 | 2.00x |
| 2026-06-04 | 1.97x |
| 2026-06-03 | 1.96x |
| 2026-06-02 | 1.95x |
| 2026-06-01 | 1.95x |
| 2026-05-29 | 1.97x |
| 2026-05-28 | 1.98x |
| 2026-05-27 | 1.96x |
| 2026-05-26 | 1.96x |
| 2026-05-22 | 1.97x |
| 2026-05-21 | 1.94x |
| 2026-05-20 | 1.95x |
| 2026-05-19 | 1.93x |
| 2026-05-18 | 1.94x |
| 2026-05-15 | 1.91x |
| 2026-05-14 | 1.93x |
| 2026-05-13 | 1.93x |
| 2026-05-12 | 1.95x |
| 2026-05-11 | 1.94x |
| 2026-05-08 | 1.93x |
| 2026-05-07 | 1.95x |
| 2026-05-06 | 1.95x |
| 2026-05-05 | 1.95x |
| 2026-05-04 | 1.93x |
| 2026-05-01 | 2.00x |
| 2026-04-30 | 2.01x |
| 2026-04-29 | 2.01x |
| 2026-04-28 | 2.03x |
| 2026-04-27 | 2.05x |
| 2026-04-24 | 2.05x |
| 2026-04-23 | 2.06x |
| 2026-04-22 | 2.10x |
| 2026-04-21 | 2.11x |
| 2026-04-20 | 2.08x |
| 2026-04-17 | 2.09x |
| 2026-04-16 | 2.07x |
| 2026-04-15 | 2.07x |
| 2026-04-14 | 2.08x |
| 2026-04-13 | 2.05x |
| 2026-04-10 | 2.03x |
| 2026-04-09 | 2.11x |
| 2026-04-08 | 2.12x |
| 2026-04-07 | 2.08x |
| 2026-04-06 | 2.12x |
| 2026-04-02 | 2.11x |
| 2026-04-01 | 2.10x |
| 2026-03-31 | 2.07x |
| 2026-03-30 | 2.05x |
| 2026-03-27 | 2.05x |
| 2026-03-26 | 2.08x |
| 2026-03-25 | 2.06x |
| 2026-03-24 | 2.07x |
| 2026-03-23 | 2.06x |
| 2026-03-20 | 2.05x |
| 2026-03-19 | 2.05x |
| 2026-03-18 | 2.06x |
| 2026-03-17 | 2.09x |
| 2026-03-16 | 2.07x |
| 2026-03-13 | 2.05x |
| 2026-03-12 | 2.05x |
| 2026-03-11 | 2.09x |
| 2026-03-10 | 2.08x |
| 2026-03-09 | 2.11x |
| 2026-03-06 | 2.09x |
| 2026-03-05 | 2.12x |
| 2026-03-04 | 2.15x |
| 2026-03-03 | 2.17x |
| 2026-03-02 | 2.19x |
| 2026-02-27 | 2.20x |
| 2026-02-26 | 2.19x |
| 2026-02-25 | 2.16x |
| 2026-02-24 | 2.19x |
| 2026-02-23 | 2.22x |
| 2026-02-20 | 2.20x |
| 2026-02-19 | 2.20x |
| 2026-02-18 | 2.18x |
| 2026-02-17 | 2.16x |
| 2026-02-13 | 2.20x |
| 2026-02-12 | 2.17x |
| 2026-02-11 | 2.24x |
| 2026-02-10 | 2.21x |
| 2026-02-09 | 2.15x |
| 2026-02-06 | 2.17x |
| 2026-02-05 | 2.17x |
| 2026-02-04 | 2.16x |
| 2026-02-03 | 2.14x |
| 2026-02-02 | 2.12x |
| 2026-01-30 | 2.13x |
| 2026-01-29 | 2.12x |
| 2026-01-28 | 2.11x |
| 2026-01-27 | 2.13x |
| 2026-01-26 | 2.11x |
| 2026-01-23 | 2.10x |
| 2026-01-22 | 2.12x |
| 2026-01-21 | 2.12x |
| 2026-01-20 | 2.13x |
| 2026-01-16 | 2.13x |
| 2026-01-15 | 2.12x |
| 2026-01-14 | 2.07x |
| 2026-01-13 | 2.03x |
| 2026-01-12 | 2.00x |
| 2026-01-09 | 2.01x |
| 2026-01-08 | 2.03x |
| 2026-01-07 | 2.02x |
| 2026-01-06 | 2.06x |
| 2026-01-05 | 2.02x |
| 2026-01-02 | 2.01x |
| 2025-12-31 | 2.01x |
| 2025-12-30 | 2.02x |
| 2025-12-29 | 2.02x |
| 2025-12-26 | 2.02x |
| 2025-12-24 | 2.03x |
| 2025-12-23 | 2.02x |
| 2025-12-22 | 2.03x |
| 2025-12-19 | 2.01x |
| 2025-12-18 | 2.01x |
| 2025-12-17 | 2.04x |
| 2025-12-16 | 2.05x |
| 2025-12-15 | 2.08x |
| 2025-12-12 | 2.09x |
| 2025-12-11 | 2.09x |
| 2025-12-10 | 2.07x |
| 2025-12-09 | 2.05x |
| 2025-12-08 | 2.06x |
| 2025-12-05 | 2.05x |
| 2025-12-04 | 2.07x |
| 2025-12-03 | 2.10x |
| 2025-12-02 | 2.10x |
| 2025-12-01 | 2.11x |
| 2025-11-28 | 2.12x |
| 2025-11-26 | 2.11x |
| 2025-11-25 | 2.12x |
| 2025-11-24 | 2.09x |
| 2025-11-21 | 2.10x |
| 2025-11-20 | 2.07x |
| 2025-11-19 | 2.07x |
| 2025-11-18 | 2.06x |
| 2025-11-17 | 2.07x |
| 2025-11-14 | 2.10x |
| 2025-11-13 | 2.11x |
| 2025-11-12 | 2.10x |
| 2025-11-11 | 2.11x |
| 2025-11-10 | 2.07x |
| 2025-11-07 | 2.02x |
| 2025-11-06 | 1.98x |
| 2025-11-05 | 2.01x |
| 2025-11-04 | 2.02x |
| 2025-11-03 | 2.05x |
| 2025-10-31 | 2.03x |
| 2025-10-30 | 2.01x |
| 2025-10-29 | 1.99x |
| 2025-10-28 | 2.06x |
| 2025-10-27 | 2.16x |
| 2025-10-24 | 2.18x |
| 2025-10-23 | 2.21x |
| 2025-10-22 | 2.20x |
| 2025-10-21 | 2.21x |
| 2025-10-20 | 2.25x |
| 2025-10-17 | 2.22x |
| 2025-10-16 | 2.21x |
| 2025-10-15 | 2.20x |
| 2025-10-14 | 2.18x |
| 2025-10-13 | 2.16x |
| 2025-10-10 | 2.17x |
| 2025-10-09 | 2.17x |
| 2025-10-08 | 2.17x |
| 2025-10-07 | 2.18x |
| 2025-10-06 | 2.15x |
| 2025-10-03 | 2.16x |
| 2025-10-02 | 2.18x |
| 2025-10-01 | 2.18x |
| 2025-09-30 | 2.23x |
| 2025-09-29 | 2.20x |
| 2025-09-26 | 2.19x |
| 2025-09-25 | 2.16x |
| 2025-09-24 | 2.18x |
| 2025-09-23 | 2.18x |
| 2025-09-22 | 2.18x |
| 2025-09-19 | 2.17x |
| 2025-09-18 | 2.17x |
| 2025-09-17 | 2.16x |
| 2025-09-16 | 2.15x |
| 2025-09-15 | 2.16x |
| 2025-09-12 | 2.17x |
| 2025-09-11 | 2.18x |
| 2025-09-10 | 2.14x |
| 2025-09-09 | 2.17x |
| 2025-09-08 | 2.17x |
| 2025-09-05 | 2.18x |
| 2025-09-04 | 2.15x |
| 2025-09-03 | 2.15x |
| 2025-09-02 | 2.15x |
| 2025-08-29 | 2.17x |
| 2025-08-28 | 2.15x |
| 2025-08-27 | 2.18x |
| 2025-08-26 | 2.17x |
| 2025-08-25 | 2.16x |
| 2025-08-22 | 2.17x |
| 2025-08-21 | 2.16x |
| 2025-08-20 | 2.17x |
| 2025-08-19 | 2.16x |
| 2025-08-18 | 2.12x |
| 2025-08-15 | 2.12x |
| 2025-08-14 | 2.13x |
| 2025-08-13 | 2.14x |
| 2025-08-12 | 2.12x |
| 2025-08-11 | 2.11x |
| 2025-08-08 | 2.10x |
| 2025-08-07 | 2.06x |
| 2025-08-06 | 2.06x |
| 2025-08-05 | 2.08x |
| 2025-08-04 | 2.08x |
| 2025-08-01 | 2.07x |
| 2025-07-31 | 2.13x |
| 2025-07-30 | 2.16x |
| 2025-07-29 | 2.14x |
| 2025-07-28 | 2.14x |
| 2025-07-25 | 2.16x |
| 2025-07-24 | 2.18x |
| 2025-07-23 | 2.07x |
| 2025-07-22 | 2.08x |
| 2025-07-21 | 2.02x |
| 2025-07-18 | 2.03x |
| 2025-07-17 | 2.05x |
| 2025-07-16 | 2.04x |
| 2025-07-15 | 2.04x |
| 2025-07-14 | 2.06x |
| 2025-07-11 | 2.06x |
| 2025-07-10 | 2.09x |
| 2025-07-09 | 2.12x |
| 2025-07-08 | 2.11x |
| 2025-07-07 | 2.12x |
| 2025-07-03 | 2.14x |
| 2025-07-02 | 2.13x |
| 2025-07-01 | 2.16x |
| 2025-06-30 | 2.15x |
| 2025-06-27 | 2.13x |
| 2025-06-26 | 2.11x |
| 2025-06-25 | 2.12x |
| 2025-06-24 | 2.15x |
| 2025-06-23 | 2.14x |
| 2025-06-20 | 2.14x |
| 2025-06-18 | 2.14x |
| 2025-06-17 | 2.13x |
| 2025-06-16 | 2.16x |
| 2025-06-13 | 2.14x |
| 2025-06-12 | 2.14x |
| 2025-06-11 | 2.13x |
| 2025-06-10 | 2.13x |
| 2025-06-09 | 2.10x |
| 2025-06-06 | 2.09x |
| 2025-06-05 | 2.08x |
| 2025-06-04 | 2.09x |
| 2025-06-03 | 2.07x |
| 2025-06-02 | 2.05x |
Showing the most recent 260 of 5,033 data points. The chart above shows the full history.
Related Metrics
About Labcorp Holdings Inc.
Labcorp Holdings, Inc. offers vital diagnostic laboratory services, enabling medical professionals, healthcare facilities, pharmaceutical firms, scientific investigators, and patients to make well-informed and confident choices. The company commenced operations on April 16, 2024, and its main office is situated in Burlington, NC.
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Adam H. Schechter